Freeline Therapeutics pioneers gene therapies for chronic illnesses
Freeline Therapeutics is at the forefront of developing groundbreaking gene therapies for chronic diseases.
Source: wbbjtv.com
Michael Parini News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Parini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Parini Today - Breaking & Trending Today
Freeline Therapeutics : Reports Second Quarter 2023 Financial Results and Business Highlights - Form 6-K -December 01, 2023 at 08:59 am EST
Freeline Reports Second Quarter 2023 Financial Results and Business Highlights Completed dosing in first cohort of Phase 1/2 GALILEO-1 trial of FLT201 in Gaucher disease; expect...
Source: marketscreener.com
Freeline Therapeutics Stock Jumps 10% On Positive Data From Trial Of FLT201
Shares of Freeline Therapeutics Holdings plc (FRLN) are gaining over 10% on Wednesday morning after the company reported positive initial clinical data from first cohort of phase 1/2 trial of FLT201, its novel gene therapy candidate in Gaucher disease.
Source: rttnews.com
Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call Transcript
Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call Transcript August 15, 2023 Freeline Therapeutics Holdings plc misses on earnings expectations. Reported EPS is $-4.16 EPS, expectations were $3.62. Operator: Good morning, everyone, and welcome to the Freeline Second Quarter 2023 Financial and Business Update Conference Call. All participants will be in a listen-only mode. […]
Source: yahoo.com